CompuGroup Medical SE & Co. KGaA (COP.DE)
EUR 21.7
(0.37%)
EUR 21.7
(0.37%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 374.5 Million EUR | 4.89% |
| 2022 | 958.16 Million EUR | 9.98% |
| 2021 | 871.19 Million EUR | 22.19% |
| 2020 | 712.95 Million EUR | 12.91% |
| 2019 | 631.42 Million EUR | 8.1% |
| 2018 | 584.1 Million EUR | 18.71% |
| 2017 | 492.03 Million EUR | 5.55% |
| 2016 | 466.15 Million EUR | 3.09% |
| 2015 | 452.17 Million EUR | 6.37% |
| 2014 | 425.07 Million EUR | 9.03% |
| 2013 | 389.85 Million EUR | 4.05% |
| 2012 | 374.67 Million EUR | 16.3% |
| 2011 | 322.17 Million EUR | 23.73% |
| 2010 | 260.38 Million EUR | 8.83% |
| 2009 | 239.25 Million EUR | 32.96% |
| 2008 | 179.94 Million EUR | -15.95% |
| 2007 | 214.08 Million EUR | 3376.66% |
| 2006 | 6.15 Million EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 238.03 Million EUR | -7.03% |
| 2024 Q2 | 66.79 Million EUR | -63.51% |
| 2023 Q1 | 246.76 Million EUR | -7.76% |
| 2023 FY | 1 Billion EUR | 4.89% |
| 2023 Q4 | 256.04 Million EUR | 6.19% |
| 2023 Q3 | 241.1 Million EUR | -7.67% |
| 2023 Q2 | 261.14 Million EUR | 5.83% |
| 2022 Q2 | 228.12 Million EUR | 2.46% |
| 2022 Q3 | 239.85 Million EUR | 5.14% |
| 2022 Q1 | 222.65 Million EUR | -4.05% |
| 2022 FY | 958.16 Million EUR | 9.98% |
| 2022 Q4 | 267.51 Million EUR | 11.53% |
| 2021 Q2 | 205.86 Million EUR | 5.38% |
| 2021 Q3 | 237.9 Million EUR | 15.56% |
| 2021 Q4 | 232.06 Million EUR | -2.45% |
| 2021 FY | 871.19 Million EUR | 22.19% |
| 2021 Q1 | 195.36 Million EUR | -0.24% |
| 2020 FY | 712.95 Million EUR | 12.91% |
| 2020 Q4 | 195.82 Million EUR | -1.53% |
| 2020 Q3 | 198.87 Million EUR | 24.88% |
| 2020 Q2 | 159.25 Million EUR | 0.16% |
| 2020 Q1 | 158.99 Million EUR | -7.0% |
| 2019 Q1 | 150.85 Million EUR | -5.17% |
| 2019 Q3 | 156.37 Million EUR | 2.04% |
| 2019 Q4 | 170.95 Million EUR | 9.33% |
| 2019 Q2 | 153.24 Million EUR | 1.58% |
| 2019 FY | 631.42 Million EUR | 8.1% |
| 2018 Q1 | 133.94 Million EUR | -1.66% |
| 2018 Q4 | 159.07 Million EUR | 15.67% |
| 2018 Q3 | 137.52 Million EUR | -10.44% |
| 2018 Q2 | 153.55 Million EUR | 14.64% |
| 2018 FY | 584.1 Million EUR | 18.71% |
| 2017 Q2 | 119.74 Million EUR | -0.38% |
| 2017 FY | 492.03 Million EUR | 5.55% |
| 2017 Q4 | 136.21 Million EUR | 17.55% |
| 2017 Q3 | 115.88 Million EUR | -3.22% |
| 2017 Q1 | 120.19 Million EUR | -4.67% |
| 2016 Q2 | 113.5 Million EUR | -1.2% |
| 2016 Q4 | 126.07 Million EUR | 12.88% |
| 2016 FY | 466.15 Million EUR | 3.09% |
| 2016 Q3 | 111.69 Million EUR | -1.6% |
| 2016 Q1 | 114.88 Million EUR | -5.26% |
| 2015 Q2 | 111.58 Million EUR | 0.58% |
| 2015 Q3 | 108.4 Million EUR | -2.85% |
| 2015 FY | 452.17 Million EUR | 6.37% |
| 2015 Q1 | 110.93 Million EUR | -3.22% |
| 2015 Q4 | 121.25 Million EUR | 11.86% |
| 2014 Q1 | 101.71 Million EUR | -4.3% |
| 2014 Q4 | 114.63 Million EUR | 11.78% |
| 2014 FY | 425.07 Million EUR | 9.03% |
| 2014 Q2 | 106.17 Million EUR | 4.38% |
| 2014 Q3 | 102.55 Million EUR | -3.41% |
| 2013 FY | 389.85 Million EUR | 4.05% |
| 2013 Q4 | 106.28 Million EUR | 11.07% |
| 2013 Q1 | 95.39 Million EUR | -22.65% |
| 2013 Q3 | 95.68 Million EUR | 3.47% |
| 2013 Q2 | 92.48 Million EUR | -3.06% |
| 2012 Q2 | 92.91 Million EUR | -2.06% |
| 2012 Q1 | 94.87 Million EUR | 8.19% |
| 2012 Q3 | 90.54 Million EUR | -2.55% |
| 2012 Q4 | 123.33 Million EUR | 36.22% |
| 2012 FY | 374.67 Million EUR | 16.3% |
| 2011 Q2 | 72.83 Million EUR | -3.45% |
| 2011 Q4 | 87.69 Million EUR | 1.73% |
| 2011 FY | 322.17 Million EUR | 23.73% |
| 2011 Q3 | 86.2 Million EUR | 18.36% |
| 2011 Q1 | 75.43 Million EUR | 2.46% |
| 2010 Q2 | 64 Million EUR | 9.2% |
| 2010 FY | 260.38 Million EUR | 8.83% |
| 2010 Q1 | 58.61 Million EUR | -14.45% |
| 2010 Q4 | 73.62 Million EUR | 14.78% |
| 2010 Q3 | 64.14 Million EUR | 0.22% |
| 2009 Q3 | 58.01 Million EUR | -1.73% |
| 2009 FY | 239.25 Million EUR | 32.96% |
| 2009 Q1 | 53.69 Million EUR | 0.0% |
| 2009 Q4 | 68.51 Million EUR | 18.1% |
| 2009 Q2 | 59.03 Million EUR | 9.95% |
| 2008 FY | 179.94 Million EUR | -15.95% |
| 2007 FY | 214.08 Million EUR | 3376.66% |
| 2006 FY | 6.15 Million EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| DocCheck AG | 12.97 Million EUR | -2786.556% |
| MeVis Medical Solutions AG | 7 Million EUR | -5247.947% |
| Nexus AG | 65.97 Million EUR | -467.651% |